Prologis Reports Strong Q2 Growth

By Bobby Samwell • Wednesday, July 16 10:18 • Permanent Link

Prologis, Inc. has released its unaudited second-quarter 2025 supplemental information, revealing significant growth and performance across various metrics when compared to the same period in 2024.

The company's strategic capital revenues for the second quarter of 2025 amounted to $147 million, compared to $155 million in the same period in 2024. Furthermore, Prologis reported total revenues of $2.184 billion for the second quarter of 2025, up from $2.008 billion in the second quarter of 2024.

Net earnings attributable to common stockholders for the three months ended June 30, 2025, were $570 million, a decrease from $860 million in the same period in 2024. Additionally, core FFO attributable to common stockholders/unitholders for the second quarter of 2025 was $1.396 billion, compared to $1.281 billion in the same period in 2024.

The company's guidance for 2025 indicates an optimistic outlook, with a projected range for net earnings attributable to common stockholders between $3.00 and $3.15 billion. Similarly, the core FFO attributable to common stockholders/unitholders is estimated to be between $5.75 billion and $5.80 billion.

In terms of capital deployment, Prologis' guidance for development stabilizations in 2025 ranges from $1.9 billion to $2.3 billion, reflecting an increase from the $2.0 billion reported in 2024. Additionally, the company projects development starts to be in the range of $2.25 billion to $2.75 billion for 2025, up from $2.5 billion in 2024.

Prologis' performance in lease proposals also demonstrated growth, with lease proposals totaling millions of square feet, reflecting continued demand for the company's logistics facilities.

Following these announcements, the company's shares moved -0.67%, and are now trading at a price of $108.62. Check out the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.